ATF2 knockdown reinforces oxidative stress-induced apoptosis in TE7 cancer cells

Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): A Potent and Selective Inhibitor of ATR Protein Kinase with Monotherapy in Vivo Antitumor Activity

(2013) Kevin M. Foote et al.   JOURNAL OF MEDICINAL CHEMISTRY

Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo

(2013) C. Posch et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Induction of caspase 8 and reactive oxygen species by ruthenium-derived anticancer compounds with improved water solubility and cytotoxicity

(2012) Vania Vidimar et al.   BIOCHEMICAL PHARMACOLOGY

The roles of ATF2 (activating transcription factor 2) in tumorigenesis

(2012) Malgorzata Gozdecka et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation

(2012) James W. Antoon et al.   CANCER BIOLOGY & THERAPY

EGFR/JIP-4/JNK2 Signaling Attenuates Cetuximab-Mediated Radiosensitization of Squamous Cell Carcinoma Cells

(2012) I. Eke et al.   CANCER RESEARCH

Impact of Breast Cancer and Combination Chemotherapy on Oxidative Stress, Hepatic and Cardiac Markers

(2012) Kamal Adel Amin et al.   Journal of Breast Cancer

ATF2 – at the crossroad of nuclear and cytosolic functions

(2012) Eric Lau et al.   JOURNAL OF CELL SCIENCE

Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma

(2012) K Kikuchi et al.   ONCOGENE

Nanosecond pulsed electric fields activate MAPK pathways in human cells

(2011) Keiko Morotomi-Yano et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway

(2011) R. Hamano et al.   CLINICAL CANCER RESEARCH

Targeting the S and G2 checkpoint to treat cancer

(2011) Tao Chen et al.   DRUG DISCOVERY TODAY

Auto-activation of c-JUNGene by Amino Acid Deprivation of Hepatocellular Carcinoma Cells Reveals a Novel c-JUN-mediated Signaling Pathway

(2011) Lingchen Fu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Protein and its function based on a subcellular localization

(2011) Jana Ćmielová et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells

(2011) P T Ferrao et al.   ONCOGENE

Cutting edge: Chk1 directs senescence and mitotic catastrophe in recovery from G2 checkpoint arrest

(2010) Angela Poehlmann et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The Resistance of Esophageal Adenocarcinoma to Bile Salt Insult is Associated with Manganese Superoxide Dismutase Expression

(2010) Suzanne C. Schiffman et al.   JOURNAL OF SURGICAL RESEARCH

Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line

(2010) Elizabeth Chang et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Transient Glutathione Depletion Determines Terminal Differentiation in HL-60 Cells

(2010) Suzanne M. Krance et al.   Oxidative Medicine and Cellular Longevity

Importance of DNA damage checkpoints in the pathogenesis of human cancers

(2010) Angela Poehlmann et al.   PATHOLOGY RESEARCH AND PRACTICE

RETRACTED: Identification of Phosphorylated p38 as a Novel DAPK-Interacting Partner during TNFα-Induced Apoptosis in Colorectal Tumor Cells

(2009) Khuloud Bajbouj et al.   AMERICAN JOURNAL OF PATHOLOGY

Bid integrates intrinsic and extrinsic signaling in apoptosis induced by α-tocopheryl succinate in human gastric carcinoma cells

(2009) Yan Zhao et al.   CANCER LETTERS

Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis

(2008) C. Habold et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE